This provider's $15.6M in total Medicare payments ranks in the 94th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 102156% from 2015 to 2023.
70% of their billing comes from a single procedure code (81455 — Test for detecting genes associated with cancer).
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 20787% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2015 | $3.5K | $88.20 | 39.68x | $3.4K | $2.2K | 25 | 21 |
| 2016 | $834.35 | $308.17 | 2.71x | $526.18 | $460.5K | 1.6K | 965 |
| 2017 | $591.88 | $270.77 | 2.19x | $321.11 | $202.6K | 722 | 570 |
| 2018 | $2.0K | $593.40 | 3.33x | $1.4K | $245.1K | 559 | 543 |
| 2019 | $2.7K | $554.06 | 4.88x | $2.1K | $445.8K | 1.0K | 1.0K |
| 2020 | $3.4K | $660.61 | 5.09x | $2.7K | $2.4M | 2.3K | 2.2K |
| 2021 | $3.1K | $887.92 | 3.45x | $2.2K | $3.9M | 3.1K | 2.9K |
| 2022 | $2.0K | $977.93 | 2.03x | $1.0K | $5.7M | 4.7K | 4.4K |
| 2023 | $2.0K | $970.63 | 2.04x | $1.0K | $2.3M | 1.9K | 1.8K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81455 | Test for detecting genes associated with cancer | 3.8K | $10.9M | $2.9K | 2.04x |
| 81194 | Gene analysis (neurotrophic receptor tyrosine kinase 1, 2, and 3) translocation analysis | 3.1K | $1.6M | $512.82 | 2.15x |
| 81301 | Microsatellite instability analysis | 4.0K | $1.4M | $345.23 | 2.41x |
| 81162 | Gene analysis (breast cancer 1 and 2) full sequence and duplication or deletion variants | 127 | $258.5K | $2.0K | 2.88x |
| 81445 | Test for detecting genes associated with cancer of body organ | 459 | $257.7K | $561.39 | 6.68x |
| 81436 | Test for detecting genes associated with colon cancer | 376 | $218.4K | $580.84 | 4.26x |
| 81479 | Molecular pathology procedure | 922 | $195.3K | $211.86 | 5.14x |
| 81404 | Molecular pathology procedure level 5 | 445 | $130.2K | $292.66 | 1.03x |
| 81235 | Gene analysis (epidermal growth factor receptor), common variants | 381 | $119.2K | $312.93 | 2.34x |
| 81275 | Gene analysis (v-Ki-ras2 Kirsten rat sarcoma viral oncogene) variants in codons 12 and 13 | 568 | $109.3K | $192.51 | 2.19x |
| 81210 | Gene analysis (v-raf murine sarcoma viral oncogene homolog B1) | 552 | $95.9K | $173.72 | 2.50x |
| 81405 | Molecular pathology procedure level 6 | 269 | $78.8K | $293.03 | 1.02x |
| 81321 | Gene analysis (phosphatase and tensin homolog), full sequence analysis | 261 | $77.0K | $295.13 | 1.03x |
| 81435 | Test for detecting genes associated with colon cancer | 125 | $74.1K | $592.51 | 5.51x |
| 81432 | Test for detecting genes associated with inherited breast cancer-related disorders | 75 | $56.0K | $746.18 | 5.68x |
| 81406 | Molecular pathology procedure level 7 | 133 | $39.1K | $294.00 | 1.02x |
| 81311 | Gene analysis for cancer (neuroblastoma) | 106 | $30.5K | $287.90 | 1.04x |
| 81403 | Molecular pathology procedure level 4 | 59 | $13.6K | $230.30 | 1.30x |
| 81450 | Test for detecting genes associated with blood related cancer | 18 | $11.4K | $635.43 | 5.51x |
| 81201 | Gene analysis (adenomatous polyposis coli), full gene sequence | 76 | $9.2K | $120.54 | 2.49x |
This provider submits charges 2.26 times higher than what Medicare actually pays.
A markup ratio of 2.26x means for every $100 Medicare pays, this provider initially charges $226. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in AL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America Holdings | Birmingham, AL | $692.7M | ⚠️ Flagged |
| Eurofins Diatherix Laboratories Llc | Huntsville, AL | $37.8M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data